LIAC FLASH LIACFLASH: a life changing IOeRT technology for oncology care
- Coordinator
- S.i.t. - Sordina Iort Technologies SpA, Italy
- Runs
- 1 December 2022 to 31 May 2025
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €3.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190151856
What the project is doing
In the project's own words, from its summary on CORDIS.
Radiation Therapy is, along with surgery, the most effective therapeutic approach for the treatment of solid tumours. Unfortunately, biological effects of radiation dose to healthy organs at risk (often surrounding targeted tumour mass) represent a major dose-limiting constraint in Radiation Therapy. This implies that tumours cannot be always successfully treated, as delivered dose might not be enough for an effective treatment, decreasing survival of these cancer patients.
LIACFLASH is an IOeRT system for cancer treatment built on a breakthrough scientific discovery: the FLASH effect, which enables delivery of high radiation dose with significantly reduced associated radiocytotoxicity, while achieving efficient tumour killing, widening the therapeutic window.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| S.i.t. - Sordina Iort Technologies SpA | Vicenza | Italy | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI